The ability of cocaine to inhibit dopamine reuptake in areas of the brain such as the nucleus accumbens where dopamine is reinforcing, is believed to be a major mechanism contributing to the abuse potential of cocaine. Although we and others have characterized the binding of cocaine and other tritiated dopamine reuptake inhibitors to the dopamine reuptake transporter protein less is known about the molecular mechanism by which the binding of a ligand such as cocaine to a sodium dependent transporter results in inhibition of reuptake. Recently, we synthesized a tritiated azido diphenylpiperazine derivative 1-[2bis(phenyl)methoxy]ethyl- 4-[3-(3'-azidophenyl)-{2,3-3H]propyl}piperazine (3azido[3H]GBR-12935.), which can be covalently incorporated (in a sodium dependent manner and with appropriate pharmacological specificity) into a single striatal 80 kDa polypeptide of the dopamine reuptake transporter protein (as detected by sodium dodecyl sulfate-polyacrylamine gel electrophoresis and fluorography). This grant proposes a series of studies that will attempt to determine the molecular composition of the dopamine transporter as well as identify regions of the transporter protein to which uptake inhibitors bind. Specific questions to be addressed are whether there are different regional isoforms of the dopamine transporter, whether several dopamine reuptake inhibitor share, a common molecular mechanism and whether dopamine reuptake inhibitors interact with the substrate (dopamine) binding site on the transporter. Methodologies proposed include further covalent incorporation studies with 3-azido [3H]GBR-12935 and comparison to covalent incorporation studies of other pharmacological probes (BTCP, metaphit, cocaine isothiocyanate, xylamine). Radiation inactivation studies are proposed to determine whether cocaine and other dopamine reuptake inhibitors interact with a protein of similar molecular weight (preliminary data suggests this is not the case). Finally chemical modification / inactivation studies are proposed to identify, compare and contrast important functional groups for the binding of cocaine and other dopamine reuptake inhibitors.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29DA007376-02
Application #
2119867
Study Section
Drug Abuse Biomedical Research Review Committee (DABR)
Project Start
1991-09-30
Project End
1996-08-31
Budget Start
1992-09-01
Budget End
1993-08-31
Support Year
2
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Reid, Malcolm S; Ho, Lauren B; Hsu, Kang et al. (2002) Evidence for the involvement of cyclooxygenase activity in the development of cocaine sensitization. Pharmacol Biochem Behav 71:37-54
Tolliver, B K; Ho, L B; Fox, L M et al. (1999) Necessary role for ventral tegmental area adenylate cyclase and protein kinase A in induction of behavioral sensitization to intraventral tegmental area amphetamine. J Pharmacol Exp Ther 289:38-47
Tolliver, B K; Newman, A H; Katz, J L et al. (1999) Behavioral and neurochemical effects of the dopamine transporter ligand 4-chlorobenztropine alone and in combination with cocaine in vivo. J Pharmacol Exp Ther 289:110-22
Reid, M S; Hsu Jr, K; Berger, S P (1997) Cocaine and amphetamine preferentially stimulate glutamate release in the limbic system: studies on the involvement of dopamine. Synapse 27:95-105
Reid, M S; Berger, S P (1996) Evidence for sensitization of cocaine-induced nucleus accumbens glutamate release. Neuroreport 7:1325-9
Reid, M S; Hsu, K; Tolliver, B K et al. (1996) Evidence for the involvement of phospholipase A2 mechanisms in the development of stimulant sensitization. J Pharmacol Exp Ther 276:1244-56
Reid, M S; Hsu Jr, K; Souza, K H et al. (1996) Neuropharmacological characterization of local ibogaine effects on dopamine release. J Neural Transm 103:967-85
Tolliver, B K; Ho, L B; Reid, M S et al. (1996) Evidence for involvement of ventral tegmental area cyclic AMP systems in behavioral sensitization to psychostimulants. J Pharmacol Exp Ther 278:411-20
Tolliver, B K; Ho, L B; Reid, M S et al. (1996) Evidence for dissociable mechanisms of amphetamine- and stress-induced behavioral sensitization: effects of MK-801 and haloperidol pretreatment. Psychopharmacology (Berl) 126:191-8
Crawford, C A; McDougall, S A; Bolanos, C A et al. (1995) The effects of the kappa agonist U-50,488 on cocaine-induced conditioned and unconditioned behaviors and Fos immunoreactivity. Psychopharmacology (Berl) 120:392-9

Showing the most recent 10 out of 11 publications